4 chapters across the catalog
The CDC and American Academy of Family Physicians are promoting trivalent flu vaccines for the upcoming season, which typically peaks between December and February. A new at-home nasal spray vaccine, FluMist, is now available in 34 states for healthy non-pregnant individuals aged 2 to 49. Health officials emphasize that vaccination reduces contagiousness and prevents severe hospitalizations.
FluMist Nasal Vaccine, Amazon Delivery and Age Restrictions
AstraZeneca launched a home-delivery service for FluMist, a nasal spray flu vaccine available for individuals aged 2 to 49. Dr. Tara Narula explained that the vaccine is not recommended for those over 49 because older immune systems may not respond effectively to the live, weakened virus. The hosts used an AI assistant to clarify the risks and joked about being "friend-zoned" by the digital bot during the inquiry.
MSG in FluMist, Pfizer Chantix Study, CDC Guidelines
The CDC has reportedly added Monosodium Glutamate (MSG) to the FluMist nasal spray vaccine. The hosts discuss the "mouthfeel" properties of MSG and its potential to cause headaches. They also critique a study funded by Pfizer that claims the smoking-cessation drug Chantix does not cause psychiatric events, noting the lead researcher was an expert witness for the company.
The emergence of FluMist, a nasal spray vaccine, is discussed in the context of the FDA's recent ban on Zycam. The hosts suggest that Zycam was removed from the market to eliminate competition for the new nasal vaccine delivery method. They also question why the seasonal flu vaccine was released unusually early in September this year.
